Submitted by Anonymous (not verified) on 1 September 2026 - 15:22
Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 9, Status: Authorised